NorthWest Biotherapeutics Inc (NWBO)

[Poor Man -]

I have no argument that it has value IF NWBO can successfully comercialize DCVax. BUT it has little value elsewhere. and it is certainly not worth "at least $2 - $3/share alone" where this conversation started.

Comment in red is simply not true. A loss carry forward is valuable for companies with similar revenue streams, it doesn't have to be a revenue stream from the same drug or process. But perhaps more important, those loss carry forwards are used to calculate valuation as a going concern. (Trust me on that one.) And any potential buyer and the seller would take those values into account, and with carry forwards over $450 million has to translate into $2 to $3 per share in value.

Again, the narrative of bankruptcy is absurd at this point.